INT MEDICAL (01501) Proposes Full Circulation of H Shares

Stock News11-12

INT MEDICAL (01501) announced that the company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H shares. According to the CSRC filing, the company has applied on behalf of certain shareholders to convert a total of 71.7866 million domestic shares held by these shareholders into H shares and list them on the Hong Kong Stock Exchange (HKEX).

Upon obtaining all necessary filings and/or approvals from relevant regulatory authorities, including the CSRC and HKEX, and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and listed for trading on the Main Board of HKEX.

In accordance with the company's articles of association, no shareholders' meeting is required to approve the conversion and listing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment